Autofluorescence lifetime imaging resolves cell heterogeneity within peripheral blood mononuclear cells.

Significance: Standard methods to characterize peripheral blood mononuclear cells (PBMCs) are often destructive, lack metabolic information, or do not provide single-cell resolution. Label-free tools that non-destructively measure single-cell metabolism within PBMCs can provide new layers of information to characterize disease state and cell therapy potential. Aim: Determine whether non-destructive fluorescence lifetime imaging microscopy (FLIM) of endogenous metabolic co-factors NAD(P)H and FAD, or optical metabolic imaging (OMI), can identify immune cell subsets and activation state within heterogeneous PBMC cultures. Approach: OMI measured single-cell metabolism of PBMCs from 3 different human donors in the quiescent or activated (phorbol 12-myristate 13-acetate and ionomycin) state. Fluorescent antibodies were used as ground truth labels for single-cell classifiers of immune cell subtypes. Results: OMI identified quiescent vs. activated PBMCs with 93% accuracy at only 2 hours post-stimulation, identified monocytes within quiescent and activated PBMCs with 96% and 88% accuracy, respectively, and identified NK cells within quiescent and activated PBMCs with 74% accuracy. Conclusion: OMI identifies activation state and immune cell subpopulations within PBMCs, enabling single-cell and label-free measurements of metabolic heterogeneity within complex PBMC samples. Therefore, OMI could enhance PBMC immunophenotyping for diagnostic and therapeutic applications. Statement of Discovery: We demonstrate that autofluorescence lifetime imaging can resolve functional and phenotypic metabolic subpopulations within a mixed culture of immune cells from human blood. This provides a new technique to characterize metabolic activity within immune cells from the peripheral blood of patients, which could improve disease diagnostics and the production of cell therapies.